Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Infringement Claims Clarified In Festo Ruling

Executive Summary

A federal appeals court decision in the Festo case further clarifies the circumstances under which pharmaceutical patent holders can assert infringement claims under the doctrine of equivalents
Advertisement

Related Content

Impax/Teva Wellbutrin SR Generic Cleared To Launch By Court, FDA
Impax/Teva Wellbutrin SR Generic Cleared To Launch By Court, FDA
Wellbutrin SR Patent Cases: Did GSK Surrender Claims To Excipients?
Wellbutrin SR Patent Cases: Did GSK Surrender Claims To Excipients?
Waxman/Hatch Reform Should Await Pending Supreme Court Decision – Hatch
Advertisement
UsernamePublicRestriction

Register

PS042584

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel